Brivekimig Evidence: Trial Results and Peer-Reviewed Publications
Hipa.ai Research · Source: PubMed & ClinicalTrials.gov / AACT · Last updated:
The clinical evidence base for Brivekimig comprises 1 peer-reviewed publications across 1 journals, 0 pivotal-trial primary-outcome rows reported to ClinicalTrials.gov, spanning indications including Glomerulosclerosis, Focal Segmental. Most recent publication: What Are Baskets, Umbrellas, and Platforms Doing in Nephrology Clinical Trials?, J Am Soc Nephrol, 2026.
Top peer-reviewed publications
Curated set of pivotal-trial result papers and recent publications in high-tier journals.
- What Are Baskets, Umbrellas, and Platforms Doing in Nephrology Clinical Trials?Lin J, Radhakrishnan J · J Am Soc Nephrol · 2026
Publications by year
2026–2026: 1 publications.
2026
1
Publications by indication
Glomerulosclerosis, Focal Segmental (1)
- What Are Baskets, Umbrellas, and Platforms Doing in Nephrology Clinical Trials?
Publications by journal
- J Am Soc Nephrol1 paper
All Brivekimig publications (1)
2026 (1 paper)
- What Are Baskets, Umbrellas, and Platforms Doing in Nephrology Clinical Trials?Lin J, Radhakrishnan J · J Am Soc Nephrol · 2026 · Derived
Sources and methodology
- Publications:
ctgov.study_references(PubMed PMIDs auto-attached by ClinicalTrials.gov to each trial), reference typesRESULT,DERIVED, andBACKGROUND. - Per-arm outcome values:
ctgov.outcome_measurementsjoined toctgov.design_outcomeswhereoutcome_type = 'PRIMARY', restricted to phasePHASE3andPHASE2/PHASE3. - Publication metadata (title, journal, year, authors): PubMed E-utilities
efetch.fcgi - Data freshness: Thu, 14 May 2026 22:25:34 GMT.
This page summarizes published evidence for general reference and does not constitute medical advice. For clinical decisions, consult the linked primary publications and your healthcare provider. Data sourced from PubMed and the ClinicalTrials.gov / AACT database maintained by the Clinical Trials Transformation Initiative (CTTI).